Abstract
Bradykinin (BK) and related peptides are produced at sites of tissue injury and inflammation and have an important role in mediating the responses of the tissues to damage and associated pain. BK causes pain by direct stimulation of nociceptors and by sensitising sensory fibres to previously non-noxious stimuli (hyperalgesia). BK exerts its biological activities by stimulating two receptor subtypes, B1 and B2, with the latter localised to sensory neurones. The B2 receptor is believed to mediate many of the effects attributed to kinins although the B1 receptor has now been shown to have an important role in hyperalgesia, notably when the hyperalgesia is secondary to an earlier inflammatory insult.
Pro-inflammatory cytokines, e.g. interleukin-1β (IL-1β) and tumour necrosis factor α (TNFα), are potent hyperalgesic agents that constitute a link between cellular injury and the development and resolution of local and systemic manifestations of inflammation. The release of TNFα by macrophages can be induced by BK and, in a model of mechanical hyperalgesia, both BK (the preferred agonist of the B2 receptor) and its metabolite, the B1 receptor agonist [des-Arg9]BK, each initiates a cascade of cytokine release which mediates hyperalgesic responses to inflammatory agents. The cytokine cascade begins with TNFα, which stimulates production of IL-1β, IL-6, IL-8, prostaglandins (PGs) and sympathomimetics.
In the above model, B1 and B2 agonists act synergistically to cause cytokine-mediated hyperalgesia, and B1 and B2 antagonists proved to be highly effective anti-hyperalgesic drugs, especially when given together. A striking synergy between B1 and B2 receptor agonists, with each other and with IL-1β, was also described in a recent study in which B1 and B2 agonists, in the presence of IL-1β, shifted the repertoire of BK receptor subtypes from B2 to B1. Since, in addition to BK-induced IL-1β, IL-1β can induce B1 receptor-mediated hyperalgesia in models of mechanical and thermal hyperalgesia, there appear to be roles for both B1 and B2 receptors in a complex network of hyperalgesic mediators in which BK and related peptides induce cytokines and vice versa.
Another group of endogenous mediators, which includes the cytokines IL-4 and IL-1O and also lipocortin-l (LC-I), inhibit the production/action of TNFα, IL-Iβ, IL-6 and IL-8, and are now reported to have anti-hyperalgesic properties. The manipulation of the relative balance of these various proteins may permit the development of novel treatments of inflammatory hyperalgesia. In the meantime, the search for anti-hyperalgesic/analgesic drugs with novel mechanisms of action includes research on antagonists of BK B2 and, especially, B1 receptors (and possibly the combination of B1 and B2 receptor antagonists) and on the (orally active) tripeptide inhibitors of IL-Iβ-mediated hyperalgesia that have been described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angel, J., Berenbaum, F., Le Denmat, C., Nevalainen, T., Masliah, J. and Fournier, C., Interleukin-1-induced prostaglandin E2 biosynthesis in human synovial cells involves the activation of cytosolic phospholipase A2 and cyclooxygenase-2, Eur. J. Biochem., 226 (1994) 125–131.
Armstrong, D., Jepson, J.B., Keele, C.A. and Stewart, J.M., Pain producing substance in human inflammatory exsudates and plasma, J. Physiol., 135 (1957) 350–370.
Auphan, N., Didonato, J.A., Rosette, C., Helmberg, A. and Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-KB activity through induction of IKB synthesis, Science, 270 (1995) 286–290.
Banner, L.R., Paterson, P., Allchome, A., Poole, S. and Woolf, C.J., Leukaemia inhibitory factor is an anti-inflammatory and analgesic cytokine, J. Neurosci., 18 (1998) 5456–5462.
Barnes, P.J., Molecular mechanisms of steroid action in asthma, J. Allergy Clin. Immunol, 97 (1996) 159–168.
Barton, B.E., Jakaway, J.P., Smith, S.R. and Siegel, M.I., Cytokine inhibition by a novel steroid, mometasone furoate, Immunopharmacol. Immunotoxicol., 13 (1991) 251–261.
Beresford, I.J.M. and Birch, P.J., Antinociceptive activity of the bradykinin antagonist HOE 140 in rat and mouse, Br. J. Pharmacol., 105 suppl (1992) 314P.
Bernheim, H.A., Gilbert, T.M. and Stitt, J.T., Prostaglandin E2 levels in third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature, J. Physiol., 301 (1980) 69–78.
Blackwell, G.J., Carnuccio, R., Dirosa, M., Flower, R.J., Parente, L. and Perisco, P., Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoid drugs, Nature, 287 (1980) 147–149.
Bogdan, C., Vodovotz, Y. and Nathan, C., Macrophage deactivation by interleukin-10, J. Exp. Med., 174 (1991) 1549–1555.
Burch, R.M., Connor, J.R. and Axelrod, J., Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts, Proc. Natl. Acad. Sci. U.S.A., 85 (1993) 6306–6309.
Cockerill, P.N., Shannon, M.F., Bert, A.G., Ryan, G.R. and Vadas, M.A., The granulocyte-macrophage colony stimulating factor/interleukin-3 locus is regulated by an inducible cyclosporin A-sensitive enhancer, Proc. Natl. Acad. Sci. U.S.A., 90 (1993) 2466–2470.
Cunha, F.Q., Lorenzetti, B.B., Poole, S. and Ferreira, S.H., Interleukin 8 as a mediator of sympathetic pain, Br. J. Pharmacol., 104 (1991) 765–767.
Cunha, F.Q., Poole, S., Lorenzetti, B.B. and Ferreira, S.H., The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia, Br. J. Pharmacol., 107 (1992) 660–664.
Cunha, F.Q., Poole, S., Lorenzetti, B.B., Veiga, F.H. and Ferreira, S.H., Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4, Br. J. Pharmacol., 126 (1999) 45–50.
Davis, A.J. and Perkins, M.N., The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat, Br. J. Pharmacol., 113 (1994) 63–68.
Davis, Ai. and Perkins, M.N., desArg9BK-induced mechanical hyperalgesia and analgesia in the rat: involvement of IL-I, prostaglandin and peripheral opioids, Br. J. Pharmacol. Proceedings (Suppl. Dec.) (1996) 74P.
Davis, C.L., Naeem, S., Phagoo, S.B., Campbell, E.A., Urban, L. and Burgess, G.M., B1 bradykinin receptors and sensory neurones, Br. J. Pharmacol., 118 (1996) 1469–1476.
De Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.G., Tevelde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H. and Devries, J., Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J. Exp. Med., 174 (1991a) 915–925.
De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G., and Devries, J.E., Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J. Exp. Med., 174 (1991b) 1209–1220.
Deeter, L.B., Martin, L.W. and Lipton, J.M., Antipyretic properties of centrally administered alphaMSH fragments in the rabbit, Peptides, 9 (1989) 1285–1288.
Di Rosa, M., Giroud, J.P. and Willoughby, D.A., Studies of the mediators of the acute inflammatory response in rats in different sites by carrageenin and turpentine, J. Pathol., 104 (1971) 15–29.
Dinarello, C.A., Interleukin-1, Rev. Infect. Dis., 6 (1984) 51–95.
Dinarello, C.A., Interleukin-1. In: August, J.T., Anders, M.W., Murad, F. (Eds.), Advances in Pharmacology Volume 25, Academic Press, London, 1994, pp. 21–51.
Dinarello, C.A., Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock, Chest 112 (6 Suppl.), (1997) 3215–3295.
Dinarello, C.A., Cannon, J.G., Wolff, S.M., Bernheim, H.A., Beutler, B., Cerami, A, Figari, I.S., Palladino, M.A. Jr. and O’Connor, J.V., Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1, J. Exp. Med., 163 (1986) 1433–1450.
Dinarello, C.A., Ikejima, T., Warner, S.J., Orencole, S.F., Lonnemann, G., Cannon, J.G. and Libby, P., Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro, J. Immunol., 139 (1987) 1902–1910.
Dray, A., Bettaney, J., Forster, P. and Perkins, M.N., Activation of a bradykinin receptor in peripheral nerve and spinal cord in the neonatal rat in vitro, Br. J. Pharmacol., 95 (1988) 1008–1011.
Dray, A and Perkins, M., Bradykinin and inflammatory pain, Trends Neurosci., 16 (1993) 99–104.
Endo, T., Ogushi, F. and Sone, S., LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-y, J. Immunol., 156 (1996) 2240–2246.
Fenton, M.J., Buras, J.A. and Donelly, R.P., IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes, J. Immunol., 149 (1992) 1283–1288.
Ferreira, S.H., Prostaglandins, aspirin-like drugs and analgesia, Nature, 240 (1972) 200–203.
Ferreira, S.H., Are macrophages the body’s alarm cells?, Agents Actions, 10 (1980) 229–230.
Ferreira, S.H. and Lorenzetti, B.B., Prostaglandin hyperalgesia, IV: a metabolic process, Prostaglandins, 21 (1981) 789–792.
Ferreira, S.H., Nakamura, M. and Castro, M.S.A, The hyperalgesic effects of prostacyclin and prostaglandin E2, Prostaglandins, 16 (1978a) 31–37.
Ferreira, S.H., Lorenzetti, B.B. and Correa, F.M.A., Central and peripheral antialgesic action of aspirin-like drugs, Eur. J. Pharmacol., 53 (1978b) 39–48.
Ferreira, S.H., Lorenzetti, B.B., Bristow, A.F. and Poole, S., Interleulcin-lP as a potent hyperalgesic agent antagonized by a tripeptide analogue, Nature, 334 (1988) 698–700.
Ferreira, S.H., Lorenzetti, B.B. and Poole, S., Bradykinin initiates cytokine mediated inflammatory hyperalgesia, Br. J. Phamracol., 110 (1993) 1227–1231.
Ferreira, S.H., Cunha, F.Q., Lorenzetti, B.B., Michelin, M.A., Perretti, M., Flower, R.J. and Poole, S., Role of lipocortin-1 in the analgesic actions of glucocorticoids, Br. J. Pharmacol., 121 (1997) 883–888.
Fiorentino, D.F., Bond, M.W. and Mosmann, T.R., Two types of mouse helper T cell IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones, J. Exp. Med., 170 (1989) 2081–2095.
Fiorentino, D.F., Zlotnik, A. and Mosmann, T.R., Howard, M. and O’Garra, A., IL-10 inhibits cytokine production by activated macrophages, J. Immunol., 147 (1991) 3815–3822.
Flower, R.J. and Blackwell, G.J., Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation, Nature, 278 (1979) 456–459.
Flower, R.J. and Rothwell, N.J., Lipocortin-1: cellular mechanisms and clinical relevance, Trends Pharmacol. Sci., 15 (1994) 71–76.
Follenfant, R.L., Nakamura-Craig, M., Henderson, B. and Higgs, G.A., Inhibition by neuropeptides of interleukin-lbeta-induced, prostaglandin-independent hyperalgesia, Br. J. Pharmacol. 98 (1989) 41–43.
Fong, Y., Tracey, K.J., Moldawer, L.L., Hesse, D.G., Manogue, K.B., Kenney, J.S., Lee, AT., Kuo, G.C., Allison, AC., Lowry, S.F. et al., Antibodies to cachectin/tumor necrosis factor reduce interleukin lbeta and interleukin 6 appearance during lethal bacteremia, J. Exp. Med. 170 (1989) 1627–1633.
Geng, Y., Blanco, F.J., Comelisson, M. and Lotz, M., Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes, J. Immunol., 155 (1995) 796–801.
Gershenwald, J.E., Fong, Y.M., Fahey, T.J., Calvano, S.E., Chizzonite, R., Kilian, P.L., Lowry, S.F. and Moldawer, L.L., Interleukin 1 receptor blockade attenuates the host inflammatory response, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4966–4970.
Hall, J.M., Bradykinin Receptors, Gen. Pharmacol., 28 (1997) 1–6.
Handwerker, H.O. and Reeh, P.W., Pain and Inflammation. In: M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.), Proceedings of the Vlth World Congress on Pain, Elsevier Science, Amsterdam, (1991), pp. 59–70.
Heapy, C.G., Farmer, S.C. and Shaw, J.S., The inhibitory effect of HOE 140 in mouse abdominal constriction assays, Br. J. Pharmacol., 104 (1991) 455P.
Henderson, B. and Poole, S., Modulation of cytokine function: therapeutic applications, In: J.T. August, M.W. Anders, and F. Murad, (Eds.), Advances in Pharmacology Volume 25, Academic Press, London, 1994, pp. 53–115.
Henderson, B., Poole, S. and Wilson, M., Bacterial-Cytokine Interactions in Health and Disease, Portland Press, London, 1998, pp. 1–375.
Hiltz, M.E. and Lipton, J.M., Anti-inflammatory activity of a COOH-terminal fragment of the neuropeptide a-MSH, Res. Commun., 3 (1989) 2282–2284.
Hiltz, M.E. and Lipton, J.M., Alpha-MSH peptides inhibit acute inflammation and contact sensitivity, Peptides, 11 (1990) 979–982.
Hirata, F., Schiffmann, E., Venkatasubamanian, K., Salomon, D. and Axelrod, J., A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids, Proc. Nat. Acad. Sci. U.S.A., 77 (1980) 2533–2536.
Howard, M. and O’Garra, A., Biological properties of IL-10, Immunol. Today, 13 (1992) 198–200.
Howard, M., O’Garra, A., Ishida, H., De Waal Malefyt, R. and de Vries, J., Biological properties of interleukin 10, J. Clin. Immunol., 12 (1992) 239–247.
Hua, X.Y., Chen, P., Fox, A. and Myers, R.R., Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-lbeta and tumor necrosis factor-alpha, J. Neurosci., 16 (1996) 4742–4748.
Jenkins, J.K., Malyak, M. and Arend, W.P., The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 production in human monocytes and neutrophils, Lymphokine and Cytokine Res., 13 (1994) 47–54.
Kanaan, S.A., Poole, S., Saadé, N.E., Jabbur, S. and Safieh-Garabedian, B., Interleukin-10 reduces endotoxin induced peripheral hyperalgesia in mice, J. Neuroimmunol., 86 (1998) 142–150.
Katsuki, H., Nakai, S., Hirai, Y., Akaji, K., Kiso, Y. and Satoh, M., Interleukin-1 beta inhibits longterm potentiation in the CA3 region of mouse hippocampal slices, Eur. J. Pharmacol. 181 (1990) 323–326.
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., and Roodman, G.D., IL-6 stimulates osteoclastlike multinucleated cell formation in long term human man-ow cultures by inducing IL-1 release, J. Immunol., 144 (1990) 4226–4230.
Lang, E., Novak, A., Reeh, P.W. and Handwerker, H.O., Chemosensitivity of fine afferents from rat skin in vitro, J. Neurophysiol., 63 (1990) 887–901.
Lauener, R.P., Goyert, S.M., Geha, R.S. and Vercelli, D., Interleukin-4 down-regulates the expression of CD 14 in normal human monocytes, Eur. J. Immunol., 20 (1990) 2375–2381.
Lew, W., Oppenheim, J.J. and Matsushima, K., Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone, J. Immunol., 140 (1988) 1895–1902.
Lord, C.J.M. and Lamb, J.R., TH2 cells in allergic inflammation: a target of immunotherapy, Cl. Exp. Allergy, 26 (1996) 756–765.
Lorenzetti, B.B. and Ferreira, S.H., Mode of analgesic action of dipyrone: Direct antagonism of inflammatory hyperalgesia, Eur. J. Pharmacol., 114 (1985) 375–381.
Lumpkin, M.D., The regulation of ACTH secretion by IL-1, Science 238 (1987) 452–454.
Lyson, K., Ceriani, G., Takashima, A, Catania, A. and Lipton, J.M., Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells, Neuroimmunomodulation, (1994) 121–126.
Marceau, F., Petitclerc, E., Deblois, D., Pradelles and Poubell, P.E., Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery, Br. J. Pharmacol., 103 (1991) 1367–1372.
March, C.J., Moseley, B., Larsen, A., Cerretti, D.P., Braedt, G., Price, V., Gillis, S., Henney, C.S., Kronheim, S.R., Grabstein, K. et al., Cloning, sequence and expression of two distinct human interleukin-1 complementary cDNAs, Nature, 341 (1985) 641–646.
Mertz, P.M., Dewitt, D.L., Stelter-Stevenson, G. and Wahl, L.M., Interleukin 10 suppression of monocyte prostaglandin H Synthase-2, J. Biol. Chem., 269 (1994) 21322–21329.
Miller, A.J., Luheshi, G.N., Rothwell, N.J. and Hopkins, S.J., Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response,.Am. J. Physiol. 272 (1997) R857–R861.
Morstyn, G. and Burgess, A.W., Hemopoietic growth factors: a review, Cancer Res. 48 (1988) 5624–5637.
Nagy, I., Pabla, R., Matesz, C., Dray, A., Woolf, C.J. and Urban, L., Cobalt uptake enables identification of capsaicin-and bradykinin-sensitive subpopulations of rat dorsal root ganglion cells in vitro, Neuroscience, (1993) 241–246.
Nakamura, M. and Ferreira, S.H., A peripheral sympathetic component in inflammatory hyperalgesia, Eur. J. Pharmacol., 135 (1987) 145–153.
Ohkubo, T., Shibata, M., Takahashi, H. and Naruse, S., Naloxone prevents the analgesic action of alpha-MSH in mice, Experientia, 41 (1985) 627–628.
Oluyomi, A.O., Poole, S., Smith, T.W. and Hart, S.L., Antinociceptive activity of peptides related to interleukin-1 beta-(193–195), Lys-Pro-Thr, Eur. J. Pharmacol., 258 (1994) 131–138.
Oswald, LP., Wynn, T.A., Sher, A. and James, S.L., Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a co-stimulatory factor for interferon gamma-induced activation, Proc. Natl. Acad. Sci. U.S.A., 89 (1992) 8676–8680.
Park, J-H., Kaushansky, K. and Levitt, L., Transcriptional regulation of interleukin-3 in primary human lymphocytes, J. Biol. Chem., 268 (1993) 6299–6308.
Perkins, M.N. and Kelly, D., Induction of bradykinin BI receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat, Br. J. Pharmacol., 110 (1993) 1441–1444.
Perkins, M.N. and Kelly, D., Interleukin-1 beta induced-desArg9 bradykinin-mediated thermal hyperalgesia in the rat, Neuropharmacology, 33 (1994)657–660.
Perkins, M.N., Campbell, E. and Dray, A., Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat, Pain, 53 (1993) 191–197.
Perkins, M.N., Kelly, D. and Davis, A.J., Bradykinin B1 and B2 receptor mechanisms and cytokine-induced hyperalgesia in the rat, Can. J. Physiol. Pharmacol., 73 (1995) 832–836.
Peretti, M., Ahluwalia, A, Hams, J.G., Goulding, N.J. and Flower, R.J., Lipocortin-1 fragments inhibit neutrophil-dependent edema in the mouse, J. Immunol. 151 (1993) 4306–4314.
Perretti, M., Ahluwalia, A, Harris, J.G., Hams, H.J., Wheller, S.K. and Flower, R.J., Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin-1, Br. J. Pharmacol., 117 (1996) 1145–1154.
Phagoo, S.B., Poole, S. and Leeb-Lundberg, L.M.F., Autoregulation of bradykinin receptors in inflammation: agonists in the presence of IL-1 beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts, J. Mol. Pharmacol., 56 (1999) 325–323.
Poole, S. and Woolf, C.J., Cytokine-nerve growth factor interactions in hyperalgesia. In: L.R. Watkins and S.F. Maier (Eds.), Progress in Inflammation research, Cytokines and Pain, Birkhauser Verlag AG, Basel, 1999, pp. 89–132.
Poole, S., Bristow, AF., Lorenzetti, B.B., Gaines Das, R.E., Smith, T.W. and Ferreira, S.H., Peripheral analgesic activities of peptides related to alpha-MSH and interleukin-1 beta 193–195, Br. J. Pharmacol., 106 (1992) 489–492.
Poole S, Cunha, F.Q., Selkirk, S., Lorenzetti, B.B. and Ferreira, S.H., Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10, Br. J. Pharmacol., 115 (1995) 684–688.
Poole, S., Lorenzetti, B.B., Cunha, J.M., Cunha, F.Q. and Ferreira, S.H., Bradykinin B1 and B2 receptors, tumour necrosis factor a and inflammatory hyperalgesia, Br. J. Pharmacol., 126 (1999a) 649–656.
Poole, S, Cunha, F.Q. and Ferreira, S.H., Hyperalgesia from subcutaneous cytokines. In: L.R. Watkins and S.F Maier (Eds.), Progress in Inflammation research, Cytokines and Pain, Birkhauser Verlag AG, Basel, (1999b), pp. 59–87.
Ralph, P., Nakoinz, I., Sampson-Johannes, A., Fong, S., Lowe, D., Min, H.-Y. and Lin, L., IL-10, T-Lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor, J. Immunol., 148 (1992) 808–814.
Relton, J.K., Strijbos, P.J., O’Shaughnessy, C.T., Carey, F., Forder, R.A., Tilders, F.J., and Rothwell, N.J., Lipocortin-1 is an endogenous inhibitor of ischaemic damage in the rat brain, J. Exp. Med., 174 (1991) 305–310.
Richards, D.B. and Lipton, J.M., Effect of alpha-MSH 11–13 (lysine-proline-valine) on fever in the rabbit, Peptides, 5 (1984) 815–817.
Rothschild, A.M. and Gascon, L.A., Sulphuric esters of polysaccharides as activators of a bradykininforming system in plasma, Nature, 212 (1966) 1364.
Rothwell, N.J., Functions and mechanisms of interleukin 1 in the brain, Trends Pharmacol. Sci., 12 (1991) 430–436.
Safieh-Garabedian, B., Poole, S., Allchome, A., Winter, J. and Woolf, C.J., Contribution of interleukin10 to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia, Br. J. Pharmacol., 115 (1995)1265–1275.
Safieh-Garabedian, B., Kanaan, S.A., Jalakhian, R.H., Poole, S., Jabbur, S.J. and Saade, N.E., Hyperalgesia induced by low doses of thymulin injections: possible involvement of prostaglandin E2, J. Neuroimmunol., 73 (1997) 162–168.
Scheinman, R.I., Gogswell, P.C., Lofquist, A.K. and Baldwin Jr., A.S., Role of transcriptional activation of iicBa in mediation of immunosuppression by glucocorticoids, Science, 270 (1995) 283–286.
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S.C. and Dinarello, C.A., Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF, Blood, 75 (1990) 40–47.
Schweizer, A., Feige, U., Fontana, A., Muller, K. and Dinarello, C.A., Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels, Agents Actions, 25 (1988) 246–251.
Seabrook, G.R., Bowery, B.J., Heavens, R., Brown, N., Ford, H., Sirinathsinghi, D.J., Borkowski, J.A., Hess, J.F., Strader, C.D. and Hill, R.G., Expression of BI and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice, Neuropharmacology, 36 (1997) 1009–1017.
Segond-Von-Banchet, G., Petersen, M. and Ileppelmann, B., Bradykinin receptors in cultured rat dorsal root ganglion cells: influence of length of time in culture, Neuroscience, 75 (1996) 1211–1218.
Seibert, K., Masferrer, J.L., Jiyi, F., Honda, A., Raz, A. and Needleman, P., Biochemical and pharmacological manipulation of cellular cyclooxygenase (COX) activity. In: B. Samuelsson, P.W. Ramwell, R. Paoletti, G. Polco, and E. Granstrom (Eds.), Advances in Prostaglandin, Thromboxane, and Leukotriene Research 21, Raven Press, New York, 1990, pp. 45–59.
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L. and Isakson, P., Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl. Acad. Sci. U.S.A, 91 (1994) 12013–12017.
Seitz, M., Dewald, B., Gerber, N. and Baggiolini, M., Enhanced production of neutrophil-activating peptide-1 interleukin-8 in rheumatoid arthritis, J. Clin. Invest., 87 (1991) 463–469.
Seitz, M., Loetscher, P., Dewald, B., Towbin, H., Ceska, M. and Baggiolini, M., Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes-regulation by IFN-y and IL-4, J. Immunol., 152 (1994) 2060–2065.
Sicuteri, F., Franciullacci, F., Franchi, G. and Del Bianco, P.L., Serotonin-bradykinin potentiation on the pain receptors in man, Life Sci., 4 (1965) 309–316.
Stefferl, A., Hopkins, S.J., Rothwell, N.J. and Luheshi, G.N., The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat, Br. J. Pharmacol., 118 (1996) 1919–1924.
Stein, B., Baldwin, A.S., Ballard, D.W., Greene, W.C., Angel, P. and Herrlich, P., Cross-coupling of the NF-kB p65 and Fos-Jun transcription factors produces potentiated biological function, EMBO J., 12 (1993) 3879–3891.
Steranka, L.R., Dehaas, C.J., Vavrek, R.J., Stewart, J.M., Enna, S.J. and Snyder, S.H., Antinociceptive effects of bradykinin antagonists, Eur. J. Pharmacol., 136 (1987) 261–262.
Steranka, L.R., Manning, D.C. and Dehass, C.J., Bradykinin as pain mediator: receptors are localized to sensory neurons and antagonists have analgesic actions, Proc. Natl. Acad. Sci. U.S.A., 85 (1988) 3245–3249.
Sterling, E.A., Barthelmäs, R., Pfeuffer, I., Schenk, B., Zarius, S., Swoboda, R., Mercurio, F. and Karin, M., Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin-2 gene in T lymphocytes, EMBO J., 8 (1989) 465–473.
Streiter, R.M., Kunkel, S.L., Showell, H.J., Remick, D.G., Phan, S.H., Ward, P.A. and Marks, R.M., Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-a LPS, and IL-113, Science, 243 (1989) 1467–1469.
Tiffany, C.W. and Burch, R.M., Bradykinin stimulates tumour necrosis factor and interleukin-1 release from macrophages, FEBS Lett., 247 (1989) 189–192.
Tilg, H., Trehus, E., Atkins, M.B., Dinarello, C.A. and Mier, J.W., interleukin-6 as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55, Blood, 83 (1994) 113–118.
Tunon De Lara, J.M., Okayama, Y., Mceuen, A.R., Heusser, C.H., Church, M.K. and Walls, A F., Release and inactivation of interleukin-4 by mast cells. In: M. Chignard, M. Pretolani, P. Renesto and B.B. Vargaftig (Eds.), Cells and cytokines in lung inflammation, Ann. N. Y. Acad. Sci., 725 (1994) 50–58.
Van Damme, J., Opdenakker, G., Simpson, R.J., Rubira, M.R., Cayphas, S., Vink, A., Billiau, A. and Van Snick, J., Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor, J. Exp. Med., 165 (1987) 914–919.
Vane, J.R., Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs, Nature, 231 (1971) 232–235.
Vannier, E., Miller, L.C. and Dinarello, C.A., Co-ordinated anti-inflammatory effects of interleukin-4: Interleukin-4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist, Proc. Natl. Acad. Sci. U.S.A., 89 (1992) 4076–4080.
Waage, A. and Bakke, O., Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes, Immunology, 63 (1988) 299–302.
Walker, J.M., Akil, H. and Watson, S.J., Evidence for homologous actions of pro-opiocortin products, Science, 210 (1980) 1247–1249.
Watkins, L.R., Wiertelak, E.P., Goehler, L.E., Smith, K.P., Martin, D. and Maier, S.F., Characterization of cytokine-induced hyperalgesia, Brain Res., 654 (1994) 15–26.
Watkins, L.R., Goehler, L.E., Relton, J., Brewer, M.T. and Maier, S.F., Mechanisms of tumour necrosis factor-alpha (TNF-alpha) hyperalgesia, Brain Res., 692 (1995) 244–250.
Whalley, E.T., Clegg, S., Stewart, J.M. and Vavrek, R.J., The effect of kinin agonists and antagonists on the pain response of the human blister base Naunyn Schmiedebergs Arch. Pharmacol., 336 (1987) 652–655.
Woolf, C.J., Allchorne, A., Safieh-Garabedian, B. and Poole, S., Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor a, Br. J. Pharmacol., 121 (1997)417–424.
Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. and Mathison, J.C., CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249 (1990) 1431–1433.
Zimecki, M., Wieczorek, Z. and Kapp, J.A., Thymocyte-macrophage interactions. Interleukin 6 produced by activated thymocytes induces interleukin 1 production by macrophages, Arch. Immunol. Ther. Exp. (Warsz), 42 (1994) 163–169.
Zlotnik, A. and Moore, K.W., Interleukin-10, Cytokine, 3 (1991) 366–371.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Poole, S., de Queiroz Cunha, F., Ferreira, S.H. (2000). Bradykinin, Cytokines and Inflammatory Hyperalgesia. In: Saadé, N.E., Apkarian, A.V., Jabbur, S.J. (eds) Pain and Neuroimmune Interactions. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4225-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4225-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6897-7
Online ISBN: 978-1-4615-4225-4
eBook Packages: Springer Book Archive